Clinical TrialID 8362

Safety and Tolerability of DMT in Healthy Adults

NCT05901012

Safety Issues|Healthy Volunteers

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
8362
Evidence Id
8362
Core Evidence Id
8362
Source Clinical Trial Id
8360
Herb2 Clinical Trial Id
HBCT008360
Nct Id
NCT05901012
Title
Safety and Tolerability of DMT in Healthy Adults
Status
Completed
Phase
Phase 1
Study Result
No
Study Condition
Safety Issues|Healthy Volunteers
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Intervention
DRUG: N,N-Dimethyltryptamine|DRUG: Placebo
Intervention Allocation
Randomized
Intervention Model
Crossover
Intervention Mask
Double
Intervention Purpose
Treatment
Gender
All
Age
Adult
Enrollment
25
Outcome Measure
Systolic Blood Pressure, Assessed 7 times on each session, up to 2 hours|Diastolic Blood Pressure, Assessed 7 times on each session, up to 2 hours|Heart rate, Assessed 7 times on each session, up to 2 hours|Respiratory rate, Assessed 7 times on each session, up to 2 hours|Oxygen saturation, Assessed 7 times on each session, up to 2 hours
Sponsor Collaborator
Universidade Federal do Rio Grande do Norte
Funded By
OTHER
Location
Hospital Universitário Onofre Lopes, Natal, RN, 59012300, Brazil
Other Id
DMTcog
Start Date
2023-04-26
Primary Completion Date
2023-07-17
Completion Date
2023-07-17
First Posted
2023-06-13
Results First Posted
Last Update Posted
2023-10-11
Study Document
Study Url
https://clinicaltrials.gov/study/NCT05901012
Title Cn
Title En
Safety and Tolerability of DMT in Healthy Adults
Bilingual Status
semi_complete